CS
NVCR icon

Credit Suisse’s NovoCure NVCR Stock Holding History

Credit Suisse’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-40,400
Closed -$4.5M – 4411
2020
Q3 		$4.5M Sell
40,400
-68,100
-63% -$5.45M ﹤0.01% 1861
2020
Q2 		$6.43M Buy
108,500
+105,400
+3,400% +$6.93M ﹤0.01% 1545
2020
Q1 		$209K Hold
3,100
– – ﹤0.01% 3623
2019
Q4 		$261K Buy
+3,100
New +$250K ﹤0.01% 3885

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse's NVCR Position: Q1 2024 in Review

Credit Suisse reduced its NovoCure (NVCR) stake by 0.7% in Q1 2024, selling an estimated $88.2K and leaving 847,520 shares worth $13.2M. The position accounts for 0.01% of the portfolio, ranked #794.

Credit Suisse first reported a position in NVCR in Q2 2016 and has held it in 32 quarters since. The position peaked at $282M in Q2 2021. 237 funds tracked by Wall St. Rank hold NVCR as of Q1 2024.

  • Credit Suisse held 847,520 shares of NovoCure worth $13.2M as of Q1 2024.
  • Credit Suisse sold 5,996 NovoCure shares in Q1 2024, an estimated $88.2K.
  • NovoCure made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #794 holding.
  • Credit Suisse first reported a position in NovoCure in Q2 2016 and has held it in 32 quarters since.
  • Credit Suisse's NovoCure position peaked at $282M in Q2 2021.
  • 237 funds tracked by Wall St. Rank held NovoCure as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.